Hematopoietic Cell Transplantation, Version 3.2025

  • Alison W. Loren
  • , Marco Mielcarek
  • , Javier Bolaños-Meade
  • , Jonathan Brammer
  • , Meredith Cowden
  • , Antonio Di Stasi
  • , Areej El-Jawahri
  • , Hany Elmariah
  • , Krishna Gundabolu
  • , Jonathan Gutman
  • , Vincent Ho
  • , Rasmus T. Hoeg
  • , Mitchell Horwitz
  • , Omer Jamy
  • , Adetola Kassim
  • , Mohamed Kharfan Dabaja
  • , Lauren Lee
  • , Aaron Logan
  • , Christina Luszcak
  • , John M. Magenau
  • Thomas G. Martin, Varun Mittal, Jonathan Moreira, Lori Muffly, Ryotaro Nakamura, Mariam Nawas, Yago Nieto, Cameron Ninos, Caspian Oliai, Genovefa Papanicolaou, Joseph Pidala, Brion Randolph, Mark A. Schroeder, Jeffrey Tessier, Jeffrey Topal, Dimitrios Tzachanis, Asya Nina Varshavsky-Yanovsky, Frankie Jones, Katie Stehman

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hematopoietic Cell Transplantation (HCT) provide expert, multi-disciplinary recommendations for autologous and allogeneic HCT based on current evidence. The NCCN Guidelines focus on pretransplant recipient evaluation, hematopoietic cell mobilization, conditioning, and the diagnosis and management of graft-versus-host disease (GVHD), a common complication of allogeneic HCT that is associated with significant morbidity. This selection from the NCCN Guidelines for HCT focuses on the diagnosis, workup, and management of acute and chronic GVHD, as well as important supportive care considerations.

Original languageEnglish
Article numbere250047
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume23
Issue number10
DOIs
StatePublished - Oct 2025

Fingerprint

Dive into the research topics of 'Hematopoietic Cell Transplantation, Version 3.2025'. Together they form a unique fingerprint.

Cite this